EXECUTION VERSION AMENDED AND RESTATED AGENCY AGREEMENT 5 AUGUST 2024 GSK plc andGLAXOSMITHKLINE CAPITAL plc and GSK CAPITAL B.V. £20,000,000,000EURO MEDIUM TERM NOTE PROGRAMME

External Document